Patients Stopping Slimming Jabs Put On Pounds at a Quadrupled Rate Than Those on Conventional Diets

New research suggests that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who end conventional diet and exercise regimens.

Findings released in a leading medical journal shows that while obese people frequently drop a large proportion of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Users purchasing such treatments should be aware of the potential of rapid weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to original mass in about 18 months.

Analyzing Treatments

The study, which examined dozens of studies involving thousands of participants, contrasted the effects of the injectable medications with conventional dieting.

Scientists point out that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Quick Regain

Doctors propose the mechanism of the injections accounts for the amplified weight return.

These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of GLP-1 levels far above than normal might result in the system to generate a reduced amount of its own natural hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' leads to appetite is unsuppressed, making binge eating a significant risk."

An Ongoing Disease?

Health authorities recommend the injections for people with weight-linked health risks, alongside recommended diet and exercise modifications.

A number of clinicians contend that, considering the high risk of weight regain, the treatment should be considered life-long.

This perspective is supported by drug manufacturers, who note that the results "underscore the persistent nature of obesity," similar to managing conditions like diabetes.

Patient Testimonies

Individuals who have stopped the medication describe a intense resurgence of appetite.

"I experienced a switch flipping and you become ravenous," described an individual.

This challenge is worsened if users have not established sustainable lifestyle or habit modifications during treatment.

Widespread Interest

Figures indicate that millions of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.

• Adoption is more common among women compared to males.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians stress that while GLP-1 drugs are effective agents for weight loss, they are not a magic solution and long-term success likely depends on integrated behavioural management.